- Home
- FBLA vs MNPR Comparison
FBLA vs MNPR Comparison
Compare FBLA & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBLA
- MNPR
- Stock Information
- Founded
- FBLA 1908
- MNPR 2014
- Country
- FBLA United States
- MNPR United States
- Employees
- FBLA N/A
- MNPR N/A
- Industry
- FBLA
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- FBLA
- MNPR Health Care
- Exchange
- FBLA NYSE
- MNPR Nasdaq
- Market Cap
- FBLA 226.5M
- MNPR 209.3M
- IPO Year
- FBLA N/A
- MNPR 2019
- Fundamental
- Price
- FBLA $11.24
- MNPR $35.17
- Analyst Decision
- FBLA
- MNPR Strong Buy
- Analyst Count
- FBLA 0
- MNPR 6
- Target Price
- FBLA N/A
- MNPR $59.60
- AVG Volume (30 Days)
- FBLA 215.7K
- MNPR 55.8K
- Earning Date
- FBLA 08-22-2025
- MNPR 08-08-2025
- Dividend Yield
- FBLA N/A
- MNPR N/A
- EPS Growth
- FBLA N/A
- MNPR N/A
- EPS
- FBLA N/A
- MNPR N/A
- Revenue
- FBLA $66,405,000.00
- MNPR N/A
- Revenue This Year
- FBLA N/A
- MNPR N/A
- Revenue Next Year
- FBLA N/A
- MNPR N/A
- P/E Ratio
- FBLA N/A
- MNPR N/A
- Revenue Growth
- FBLA N/A
- MNPR N/A
- 52 Week Low
- FBLA $9.81
- MNPR $1.72
- 52 Week High
- FBLA $12.74
- MNPR $54.30
- Technical
- Relative Strength Index (RSI)
- FBLA N/A
- MNPR 51.51
- Support Level
- FBLA N/A
- MNPR $31.17
- Resistance Level
- FBLA N/A
- MNPR $35.01
- Average True Range (ATR)
- FBLA 0.00
- MNPR 2.10
- MACD
- FBLA 0.00
- MNPR 0.11
- Stochastic Oscillator
- FBLA 0.00
- MNPR 46.49
About FBLA FB BANCORP INC
FB Bancorp Inc is a holding company. The company operates through its subsidiary Fidelity Bank. Fidelity business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market areas. The services of the company also include residential construction loans, commercial real estate loans (which includes commercial mortgage, commercial construction and land development loans), commercial loans (which includes commercial and industrial, small business and other commercial loans not secured by real estate), home equity loans and lines of credit, and consumer loans.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.